Skip to main content

Bernie Sanders: ‘Prohibition Of Marijuana Has Also Failed’

Independent U.S. Sen. Bernie Sanders of Vermont said he’s still “thinking about” a possible run for the presidency in 2020 — and if he does run, it’s a safe bet that marijuana reform will be one of his priorities.

That might not be news to anyone who followed Sanders’ 2016 presidential campaign, during which he regularly railed against the failed drug war and made a powerful call for federal cannabis legalization while introducing the Senate’s first-ever bill to deschedule marijuana. But in his new book, “Where We Go from Here: Two Years in the Resistance,” the senator again emphasized the harms of prohibition.

“How many young people’s lives got off to a bad start because of a police record related to marijuana?” he writes, noting that even a simple possession conviction can make it more difficult to find a job, rent an apartment, or get admitted to college.

“The good news is that many states and cities across the country are taking action to undo the damage caused by the war on drugs,” Sanders says in the book, which was released on Nov. 27, 2018. “More and more states are moving to decriminalize or legalize the possession of marijuana, and some have passed legislation to expunge prior misdemeanor convictions.

“The prohibition of alcohol in the 1920s was a failed policy. The prohibition of marijuana has also failed.”

Speaking at George Washington University on Nov. 27, 2018, in Washington, D.C., Sanders talked about some of the main points in his book, which reflects on the last two years under President Donald Trump’s administration and makes arguments for progressive policies moving forward.

Sanders — who has co-sponsored several far-reaching marijuana reform bills and called on supporters to pressure Congress to legalize cannabis — said a lot of lessons can be drawn from the national conversation around issues like mass incarceration and police brutality.

“What we learned is that the American people, including many conservatives, understand that we need fundamental reform of a broken criminal justice system, which includes by the way, ending this disastrous so-called war on drugs, which has destroyed many lives,” he said in the speech.

Sanders also fielded a question on many people’s minds as we head into 2020 presidential campaign season: Is he going to run?

It wasn’t a question he seemed especially enthusiastic about answering, Politico reported, as the senator has maintained that voters should remain focused on policy matters and not what he described as “personality politics.” Nonetheless, he conceded that he’s considering another campaign and would be inclined to run if it was clear that he’d be able to defeat Trump.

“The issue is not ego,” he said. “It is the understanding that we’re in a pivotal moment in American history.”

This article has been republished from Marijuana Moment under a content syndication agreement. Read the original article here.

Featured Image: Bernie Sanders, campaigning for the U.S. presidency, attends a rally in New Orleans on July 26, 2015. The independent Vermont senator wrote a new book, “Where We Go from Here: Two Years in the Resistance,” and blasted the war on drugs as a failure that wrought a large human toll in terms of lost job, housing, and education opportunities due to criminal records, (Photo by Nick Solari via Wikimedia Commons; used with a Creative Commons Attribution-ShareAlike 2.0 Generic license)

.

Original Article Source: https://www.marijuana.com/news/2018/11/bernie-sanders-prohibition-of-marijuana-has-also-failed/

Comments

Post a Comment

Popular posts from this blog

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...
Post a Comment
Read more

Can Medical Marijuana Help Aging Parents With Dementia?

For decades, marijuana, even for medical uses, was demonized or questioned.  When states like Colorado legalized it for recreational use, more studies began to determine provable efficacy for its use as a medicine. The Federal government still classifies marijuana the same way it classifies heroin: harmful and with no medical benefits. Now we can see that this is wrong. When states legalized marijuana, referred to as cannabis here, they had an interest in getting data to see what good it could do. Proving efficacy could increase medical marijuana sales, benefit people who might at least find some medical use, and overall would bring tax dollars into the state coffers. Without funding studies, the Federal government has done very little to demonstrate what good cannabis can do. After all, if the presumption is that it helps nothing, there would be no motivation to determine with scientific data that it does anyone any good. But we have convincing data now about its beneficial use ...
Post a Comment
Read more

Cannabis Watch: Canopy Growth To Book Charge Of Up To $568 Million As Marijuana Restructuring Continues

Canopy Growth Corp. said early Thursday it was halting a range of operations across three continents and expects its restructuring plans to result in a charge of up to C$800 million (567.9 million) in the fiscal fourth quarter. U.S.-traded shares US:CGC CA:WEED of the cannabis company fell 1.9% in afternoon trading. Canopy said it was selling operations in Africa, curtailing cultivation of hemp in the U.S. and Columbia, and shutting down an indoor production facility in Canada. The announcement will result in 85 job cuts, the company said. “When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn,” Canopy Chief Executive David Klein said in a statement. Read: As cannabis industry stays largely quiet on coronavirus, this CEO has been sounding the alarm Canopy’s restructuring announcement was expected by investors, Cowen analyst Vivien Azer wrote in a note to clients Thursday. Azer rate...
Post a Comment
Read more